Skip to main content
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
Published Web Location
http://europepmc.org/articles/PMC3610685?pdf=renderNo data is associated with this publication.
Abstract
Anti-tumor necrosis factor alpha (anti-TNF) biologic therapy is a widely used treatment for rheumatoid arthritis (RA). It is unknown why some RA patients fail to respond adequately to anti-TNF therapy, which limits the development of clinical biomarkers to
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.